Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública (28)

2024

  1. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease

    BMJ Open, Vol. 14, Núm. 4

2022

  1. Incidence of myeloid neoplasms in Spain (2002–2013): a population-based study of the Spanish network of cancer registries

    Scientific Reports, Vol. 12, Núm. 1

  2. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study

    Annals of medicine, Vol. 54, Núm. 1, pp. 379-392

2021

  1. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1

  2. Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study

    Scientific reports, Vol. 11, Núm. 1, pp. 5375

  3. Consumption of ultra-processed foods and drinks and colorectal, breast, and prostate cancer

    Clinical Nutrition, Vol. 40, Núm. 4, pp. 1537-1545

  4. Effect of time of day of recreational and household physical activity on prostate and breast cancer risk (MCC-Spain study)

    International Journal of Cancer, Vol. 148, Núm. 6, pp. 1360-1371

  5. Occupational heat exposure and breast cancer risk in the MCC-Spain study

    Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 2, pp. 364-372

  6. Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study

    Scientific Reports, Vol. 11, Núm. 1

  7. Social mobility and healthy behaviours from a gender perspective in the Spanish multicase-control study (MCC-Spain)

    PLoS ONE, Vol. 16, Núm. 5 May

2020

  1. Association between polyphenol intake and breast cancer risk by menopausal and hormone receptor status

    Nutrients, Vol. 12, Núm. 4

  2. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses

    BMC medicine, Vol. 18, Núm. 1, pp. 229

  3. Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study (Frontiers in Pharmacology, (2020), 11, 10.3389/fphar.2020.00860)

    Frontiers in Pharmacology

  4. Dietary and circulating fatty acids and ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 9, pp. 1739-1749

  5. Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 146, Núm. 12, pp. 3267-3280

  6. Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study

    Frontiers in Pharmacology, Vol. 11

  7. Quality of life in a cohort of 1078 women diagnosed with breast cancer in spain: 7-year follow-up results in the mcc-spain study

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 22, pp. 1-16

  8. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

    Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602

  9. Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort

    International Journal of Cancer, Vol. 147, Núm. 8, pp. 2042-2052

  10. Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population

    Scientific Reports, Vol. 10, Núm. 1